| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
94,670,000 |
| Market
Cap: |
90.88(M) |
| Last
Volume: |
940,193 |
Avg
Vol: |
714,677 |
| 52
Week Range: |
$0.754 - $7.66 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Assertio Therapeutics is a pharmaceutical company. Co.'s primary marketed products include: INDOCIN® (indomethacin) Suppositories and INDOCIN® (indomethacin) Oral Suspension, which is a suppository form and oral solution of indomethacin, a nonsteroidal anti-inflammatory drug (NSAID), approved for moderate to severe rheumatoid arthritis, ankylosing spondylitis and osteoarthritis; CAMBIA® (diclofenac potassium for oral solution), which is a prescription NSAID indicated for the acute treatment of migraine attacks in adults; and Otrexup® (methotrexate) injection, used to treat adults with severe, active rheumatoid arthritis, and children with active polyarticular juvenile idiopathic arthritis.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Higgins Arthur J |
Director, President and CEO |
• • – |
2019-08-19 |
4 |
B |
$1.61 |
$40,243 |
I/I |
25,000 |
175,000 |
2.66 |
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2019-08-15 |
4 |
D |
$1.61 |
$829 |
D/D |
(515) |
41,655 |
|
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2019-08-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,814 |
42,170 |
|
- |
|
| Bukofzer Stan |
SVP, Chf Scitfc & Tech Officer |
• – – |
2019-08-13 |
4 |
B |
$1.56 |
$6,228 |
D/D |
4,000 |
26,936 |
2.74 |
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2019-08-12 |
4/A |
B |
$1.54 |
$31,313 |
D/D |
20,000 |
41,356 |
2.74 |
- |
|
| Higgins Arthur J |
Director, President and CEO |
• • – |
2019-08-12 |
4 |
B |
$1.54 |
$76,900 |
I/I |
50,000 |
150,000 |
2.66 |
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2019-08-12 |
4 |
B |
$1.54 |
$29,773 |
D/D |
19,000 |
40,356 |
2.74 |
- |
|
| Dawes Karen A |
Director |
– • – |
2019-06-13 |
4 |
AS |
$3.18 |
$39,794 |
D/D |
(12,500) |
100,423 |
|
- |
|
| Mckee William |
Director |
– • – |
2019-05-09 |
4 |
AS |
$4.70 |
$58,699 |
D/D |
(12,500) |
67,846 |
|
- |
|
| Mckee William |
Director |
– • – |
2019-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
80,346 |
|
- |
|
| Staple Peter D |
Director |
– • – |
2019-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
207,880 |
|
- |
|
| Tyree James L |
Director |
– • – |
2019-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
80,590 |
|
- |
|
| Dawes Karen A |
Director |
– • – |
2019-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
112,923 |
|
- |
|
| Fogarty James P |
Director |
– • – |
2019-05-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
106,796 |
|
- |
|
| Mckee William |
Director |
– • – |
2019-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
39,584 |
49,096 |
|
- |
|
| Lavigne Louis J Jr |
Director |
– • – |
2019-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,250 |
58,296 |
|
- |
|
| Staple Peter D |
Director |
– • – |
2019-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
39,584 |
176,630 |
|
- |
|
| Tyree James L |
Director |
– • – |
2019-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
39,584 |
49,340 |
|
- |
|
| Dawes Karen A |
Director |
– • – |
2019-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
39,584 |
81,673 |
|
- |
|
| Fogarty James P |
Director |
– • – |
2019-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
39,584 |
75,546 |
|
- |
|
| Bukofzer Stan |
SVP, Chf Scitfc & Tech Officer |
• – – |
2019-04-02 |
4 |
D |
$5.16 |
$38,359 |
D/D |
(7,434) |
22,936 |
|
- |
|
| Bukofzer Stan |
SVP, Chf Scitfc & Tech Officer |
• – – |
2019-04-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,370 |
30,370 |
|
- |
|
| Peisert Daniel A. |
SVP and CFO |
• – – |
2019-03-14 |
4 |
B |
$4.18 |
$25,069 |
D/D |
6,000 |
21,356 |
2.74 |
- |
|
| Bukofzer Stan |
SVP, Chf Scitfc & Tech Officer |
• – – |
2019-03-14 |
4 |
B |
$4.13 |
$20,658 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| Higgins Arthur J |
Director, President and CEO |
• • – |
2019-03-14 |
4 |
B |
$4.17 |
$41,700 |
I/I |
10,000 |
100,000 |
2.66 |
- |
|
246 Records found
|
|
Page 2 of 10 |
|
|
0.09 (8.57%) 
